Related content

Ovarian sensitivity to follicle stimulating hormone is blunted in normo-ovulatory women with Down's syndrome.

By Cento R M   Ragusa L   Proto C   Alberti A   Fiore G   Colabucci F   Lanzone A  

Human Reproduction, Vol. 12, Iss. 8, 1997-08 ,pp. : 1709-1713

Oxford University Press

Access to resources Recommend Favorite

Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation??

By Caserta Donatella   Lisi Franco   Marci Roberto   Ciardo Francesca   Fazi Alessandra   Lisi Roberta   Moscarini Massimo  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 862-866

Informa Healthcare

Access to resources Recommend Favorite

The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women

By Westergaard Lars G.   Erb Karin   Laursen Steen   Rasmussen Per E.   Rex Sven  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1209-1213

Oxford University Press

Access to resources Recommend Favorite

Recombinant follicle stimulating hormone

By  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1418-1420

Oxford University Press

Access to resources Recommend Favorite

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol

By Griesinger G.   Schultze-Mosgau A.   Dafopoulos K.   Schroeder A.   Schroer A.   von Otte S.   Hornung D.   Diedrich K.   Felberbaum R.  

Human Reproduction, Vol. 20, Iss. 5, 2005-05 ,pp. : 1200-1206

Oxford University Press

Access to resources Recommend Favorite